| Cat. No. |
Product Name / Activity |
| 1462 |
AACOCF3 |
| Phospholipase A2 inhibitor |
| 6316 |
ASB 14780 |
| Potent and selective cytosolic phospholipase A2 alpha (cPLA2α) inhibitor; active in vivo; orally bioavailable |
| 1437 |
D609 |
| Selective PC-PLC inhibitor |
| 6755 |
Darapladib |
| Potent lp-PLA2 inhibitor |
| 7462 |
ET 18-OCH3 |
| Selective PI-PLC inhibitor, also PAF receptor agonist |
| 3600 |
FIPI |
| Phospholipase D inhibitor |
| 7407 |
LEI 401 |
| High affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor |
| 4894 |
ML 299 |
| Potent inhibitor of PLD1 and PLD2; CNS penetrant |
| 1842 |
RHC 80267 |
| Diacylglycerol lipase inhibitor. Weak inhibitor of PLC and PLA2 |
| 1268 |
U 73122 |
| Phospholipase C inhibitor |
| 4133 |
U 73343 |
| Analog of U 73122 (Cat. No. 1268) |
| 4171 |
VU 0364739 hydrochloride |
| Potent and selective PLD2 inhibitor |
| 2522 |
YM 26734 |
| Secretory phospholipase A2 (sPLA2) inhibitor |